• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依地酸钙钠螯合疗法治疗神经毒性。

EDTA Chelation Therapy for the Treatment of Neurotoxicity.

机构信息

Department of Biomedical Sciences for Health, University of the Study of Milan, 20133 Milan, Italy.

出版信息

Int J Mol Sci. 2019 Feb 26;20(5):1019. doi: 10.3390/ijms20051019.

DOI:10.3390/ijms20051019
PMID:30813622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6429616/
Abstract

Neurotoxicity can be caused by numerous direct agents, of which toxic metals, organophosphorus pesticides, air pollution, radiation and electromagnetic fields, neurotoxins, chemotherapeutic and anesthetic drugs, and pathogens are the most important. Other indirect causes of neurotoxicity are cytokine and/or reactive oxygen species production and adoptive immunotherapy. The development of neurodegenerative diseases has been associated with neurotoxicity. Which arms are useful to prevent or eliminate neurotoxicity? The chelating agent calcium disodium ethylenediaminetetraacetic acid (EDTA)-previously used to treat cardiovascular diseases-is known to be useful for the treatment of neurodegenerative diseases. This review describes how EDTA functions as a therapeutic agent for these diseases. Some case studies are reported to confirm our findings.

摘要

神经毒性可由多种直接因素引起,其中有毒金属、有机磷农药、空气污染、辐射和电磁场、神经毒素、化疗和麻醉药物以及病原体最为重要。细胞因子和/或活性氧物质产生以及过继免疫疗法是神经毒性的其他间接原因。神经退行性疾病的发生与神经毒性有关。哪些方法有助于预防或消除神经毒性?先前用于治疗心血管疾病的络合剂钙二钠乙二胺四乙酸(EDTA)已知对治疗神经退行性疾病有效。本综述描述了 EDTA 如何作为这些疾病的治疗剂发挥作用。报告了一些病例研究以证实我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/a91aa067130f/ijms-20-01019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/a39064df9d57/ijms-20-01019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/48743884d989/ijms-20-01019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/9f293d1e5319/ijms-20-01019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/c11515d7a309/ijms-20-01019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/a721753d3c07/ijms-20-01019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/a91aa067130f/ijms-20-01019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/a39064df9d57/ijms-20-01019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/48743884d989/ijms-20-01019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/9f293d1e5319/ijms-20-01019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/c11515d7a309/ijms-20-01019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/a721753d3c07/ijms-20-01019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9488/6429616/a91aa067130f/ijms-20-01019-g006.jpg

相似文献

1
EDTA Chelation Therapy for the Treatment of Neurotoxicity.依地酸钙钠螯合疗法治疗神经毒性。
Int J Mol Sci. 2019 Feb 26;20(5):1019. doi: 10.3390/ijms20051019.
2
Efficacy of chelation therapy to remove aluminium intoxication.螯合疗法去除铝中毒的疗效。
J Inorg Biochem. 2015 Nov;152:214-8. doi: 10.1016/j.jinorgbio.2015.09.007. Epub 2015 Sep 24.
3
Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.铅螯合疗法对慢性肾脏病有效吗?一项荟萃分析。
Nephrology (Carlton). 2014 Jan;19(1):56-9. doi: 10.1111/nep.12162.
4
EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.乙二胺四乙酸螯合疗法降低糖尿病患者心血管事件发生率
Curr Cardiol Rep. 2015 Nov;17(11):96. doi: 10.1007/s11886-015-0656-y.
5
EDTA chelation therapy for cardiovascular disease: a systematic review.乙二胺四乙酸螯合疗法用于心血管疾病:一项系统评价
BMC Cardiovasc Disord. 2005 Nov 1;5:32. doi: 10.1186/1471-2261-5-32.
6
Metal chelation therapy in rheumathoid arthritis: a case report. Successful management of rheumathoid arthritis by metal chelation therapy.类风湿关节炎的金属螯合疗法:病例报告。金属螯合疗法成功治疗类风湿关节炎。
Biometals. 2011 Dec;24(6):1093-8. doi: 10.1007/s10534-011-9467-9. Epub 2011 Jun 8.
7
EDTA chelation therapy in the treatment of vascular disease.乙二胺四乙酸螯合疗法治疗血管疾病
J Cardiovasc Nurs. 1996 Apr;10(3):78-86. doi: 10.1097/00005082-199604000-00008.
8
Chelation therapy in the treatment of cardiovascular diseases.螯合疗法治疗心血管疾病。
J Clin Lipidol. 2016 Jan-Feb;10(1):58-62. doi: 10.1016/j.jacl.2015.09.005. Epub 2015 Sep 25.
9
EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.新临床试验及数百万患者常规使用后对依地酸钙钠螯合作用的再评价:初步发现和风险/获益评估综述。
Toxicol Mech Methods. 2013 Jan;23(1):11-7. doi: 10.3109/15376516.2012.730562. Epub 2012 Oct 19.
10
Does calcium disodium EDTA slow CKD progression?依地酸钙钠能否延缓慢性肾脏病的进展?
Am J Kidney Dis. 2012 Oct;60(4):503-6. doi: 10.1053/j.ajkd.2012.07.006.

引用本文的文献

1
Pharmacokinetics of metal excretion following different doses of sodium EDTA infusion.不同剂量乙二胺四乙酸钠输注后金属排泄的药代动力学
Metallomics. 2025 May 5;17(5). doi: 10.1093/mtomcs/mfaf010.
2
Silver nanoparticles can be sampled by ultrafiltration probe but elution into & recovery from plasma and Dulbecco's Phosphate Buffered Saline differs .银纳米粒子可以通过超滤探针取样,但从等离子体和 Dulbecco's Phosphate Buffered Saline 中洗脱和回收的方法不同。
PeerJ. 2024 Oct 24;12:e18388. doi: 10.7717/peerj.18388. eCollection 2024.
3
Copper ions: The invisible killer of cardiovascular disease (Review).

本文引用的文献

1
Herpesviridae Seropositivity in Patients with Multiple Sclerosis: First Polish Study.多发性硬化症患者的疱疹病毒科血清阳性:波兰的首次研究。
Eur Neurol. 2018;80(5-6):229-235. doi: 10.1159/000496402. Epub 2019 Jan 18.
2
The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.病毒和环境风险因素在多发性硬化症发病机制中的相互作用。
Int J Mol Sci. 2019 Jan 14;20(2):303. doi: 10.3390/ijms20020303.
3
The role of infections in multiple sclerosis.感染在多发性硬化症中的作用。
铜离子:心血管疾病的隐形杀手(综述)。
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13334. Epub 2024 Sep 20.
4
Structural information in therapeutic peptides: Emerging applications in biomedicine.治疗性肽中的结构信息:在生物医学中的新兴应用。
FEBS Open Bio. 2025 Feb;15(2):254-268. doi: 10.1002/2211-5463.13847. Epub 2024 Jun 14.
5
A genetically engineered neuronal membrane-based nanotoxoid elicits protective immunity against neurotoxins.一种基于基因工程改造的神经元膜纳米类毒素可引发针对神经毒素的保护性免疫。
Bioact Mater. 2024 May 9;38:321-330. doi: 10.1016/j.bioactmat.2024.05.006. eCollection 2024 Aug.
6
Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results.螯合疗法联合抗氧化剂补充可降低多发性硬化症中的氧化应激和炎症:初步结果。
Antioxidants (Basel). 2023 Jun 24;12(7):1338. doi: 10.3390/antiox12071338.
7
Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline.使用左氧氟沙星、环丙沙星、半缩醛酯前药和四环素对乙二胺四乙酸(EDTA)处理的兔子进行螯合药物生物利用度研究的开发与评估。
Pharmaceutics. 2023 May 24;15(6):1589. doi: 10.3390/pharmaceutics15061589.
8
Neuron Protection by EDTA May Explain the Successful Outcomes of Toxic Metal Chelation Therapy in Neurodegenerative Diseases.乙二胺四乙酸的神经保护作用可能解释了毒性金属螯合疗法在神经退行性疾病中取得成功的原因。
Biomedicines. 2022 Oct 4;10(10):2476. doi: 10.3390/biomedicines10102476.
9
SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.SARS-CoV-2 可能通过依赖钙的 RGD-整联蛋白相互作用与宿主细胞结合,这提示肺部 EDTA 螯合疗法可能是 COVID-19 的一种新的治疗方法。
Immunobiology. 2021 Jan;226(1):152021. doi: 10.1016/j.imbio.2020.152021. Epub 2020 Nov 5.
10
EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update.乙二胺四乙酸螯合疗法治疗神经退行性疾病:最新进展
Biomedicines. 2020 Aug 3;8(8):269. doi: 10.3390/biomedicines8080269.
Mult Scler. 2019 Jun;25(7):891-901. doi: 10.1177/1352458518823940. Epub 2019 Jan 14.
4
Radiation-induced astrocyte senescence is rescued by Δ133p53.Δ133p53 挽救辐射诱导的星形胶质细胞衰老。
Neuro Oncol. 2019 Mar 18;21(4):474-485. doi: 10.1093/neuonc/noz001.
5
Healthcare Workers Occupationally Exposed to Ionizing Radiation Exhibit Altered Levels of Inflammatory Cytokines and Redox Parameters.职业暴露于电离辐射的医护人员表现出炎症细胞因子水平和氧化还原参数的改变。
Antioxidants (Basel). 2019 Jan 1;8(1):12. doi: 10.3390/antiox8010012.
6
The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders.NADPH 氧化酶和氧化应激在神经退行性疾病中的作用。
Int J Mol Sci. 2018 Nov 30;19(12):3824. doi: 10.3390/ijms19123824.
7
Neurotoxicity of anesthetics: Mechanisms and meaning from mouse intervention studies.麻醉药的神经毒性:来自小鼠干预研究的机制和意义。
Neurotoxicol Teratol. 2019 Jan-Feb;71:22-31. doi: 10.1016/j.ntt.2018.11.004. Epub 2018 Nov 22.
8
Oxidative stress in the neurodegenerative brain following lifetime exposure to lead in rats: Changes in lifespan profiles.大鼠终生暴露于铅后神经退行性变脑内的氧化应激:寿命特征的变化
Toxicology. 2019 Jan 1;411:101-109. doi: 10.1016/j.tox.2018.11.003. Epub 2018 Nov 13.
9
Botulinum and Tetanus Neurotoxins.肉毒杆菌和破伤风神经毒素。
Annu Rev Biochem. 2019 Jun 20;88:811-837. doi: 10.1146/annurev-biochem-013118-111654. Epub 2018 Nov 2.
10
Cross Talk Between Aluminum and Genetic Susceptibility and Epigenetic Modification in Alzheimer's Disease.阿尔茨海默病中铝与遗传易感性和表观遗传修饰的对话。
Adv Exp Med Biol. 2018;1091:173-191. doi: 10.1007/978-981-13-1370-7_10.